USAMRMC is conducts research to deliver the medical solutions to enhance, protect and treat the warfighter.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
May 26, 2021
Inhalon Biopharma
|
Grant | $7M | Biopharma | Yes |
May 18, 2021
Oculogica
|
Grant | $2M | Health Care | Yes |
Sep 24, 2020
Lumen Bioscience
|
Grant | $4M | Biopharma | Yes |
Feb 19, 2018
Medcura
|
Grant | $1.40M | Health Care | Yes |
Aug 14, 2017
Cytosorbents
|
Grant | $719K | Biotechnology | Yes |
U.S. Army Medical Research & Development Command has had 3 exits. U.S. Army Medical Research & Development Command most notable exits include SmartCells , Cytosorbents
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Dec 2, 2010 | SmartCells | M&A | Biotechnology | Detail |
Aug 18, 2006 | Cytosorbents | IPO | Biotechnology | Detail |
Feb 20, 1998 | Lexicon Pharmaceuticals | IPO | Bioinformatics | Detail |